Back to Search Start Over

Predictive Factors, Treatment, and Outcomes of Coagulase-Negative Staphylococcal Peritonitis in Malaysian Peritoneal Dialysis Patients: A Single-Center Study.

Authors :
Lau SY
Bee BC
Wong HS
Omar MS
Bahari N
Source :
International journal of nephrology [Int J Nephrol] 2022 Apr 11; Vol. 2022, pp. 8985178. Date of Electronic Publication: 2022 Apr 11 (Print Publication: 2022).
Publication Year :
2022

Abstract

Aims: Coagulase-negative Staphylococci (CoNS) are frequently isolated in peritoneal dialysis (PD)-related peritonitis with a high rate of relapse and repeat peritonitis after initial response to antimicrobials. The optimal treatment regimen for CoNS peritonitis remains debatable. Hence, this study aimed to describe the clinical and microbiologic characteristics of CoNS peritonitis in a PD center and determine predictive factors influencing the outcomes.<br />Methods: All cases of CoNS peritonitis in Selayang Hospital between 2011 and 2019 were reviewed retrospectively.<br />Results: A total of 906 episodes of peritonitis were recorded; 140 episodes (15%) in 98 patients were caused by CoNS. The oxacillin and gentamicin resistance rates were 47% and 46%, respectively. The overall primary response rate was 90%, and the complete cure rate was 79%. Patients with concomitant exit-site infection (odds ratio (OR) 0.06, 95% confidence interval (CI) 0.01 to 0.40, P < 0.01) and history of recent systemic antibiotic use (OR 0.04, 95% CI 0.01 to 0.82, P =0.04) were less likely to achieve primary response. CoNS episodes that were treated with beta-lactam-based or vancomycin-based therapy had a similar primary response rate and complete cure rate. The rates of relapse and repeat were 12% and 16%, respectively. Relapsed episodes (OR 0.35, 95% CI 0.13 to 0.97, P =0.04) had a significantly lower complete cure rate than the first episodes.<br />Conclusion: Relapsed CoNS peritonitis was common and was associated with worse outcomes than the first episode of CoNS peritonitis. Oxacillin resistance was common, but the treatment outcome remained favourable when a beta-lactam-based regimen was used as empirical therapy.<br />Competing Interests: The authors declare that they have no conflicts of interest.<br /> (Copyright © 2022 Siew Yan Lau et al.)

Details

Language :
English
ISSN :
2090-214X
Volume :
2022
Database :
MEDLINE
Journal :
International journal of nephrology
Publication Type :
Academic Journal
Accession number :
35449558
Full Text :
https://doi.org/10.1155/2022/8985178